Ranking · Trials
Active clinical trials
Interventional studies registered on ClinicalTrials.gov whose overall status is RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION or ACTIVE_NOT_RECRUITING and whose conditions map to this cancer or one of its descendants in the NCIt hierarchy.
Computedci-active-trials-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Active clinical trials (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Lung Neoplasm | 2,644 | 100 | Medium confidence | clinicaltrials | inputs
ranking row 2580654 |
| 2 | = | Malignant Breast Neoplasm | 2,627 | 97.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580655 |
| 3 | = | Non-Hodgkin Lymphoma | 2,168 | 94.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580656 |
| 4 | = | Leukemia | 1,769 | 91.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580657 |
| 5 | = | Malignant Prostate Neoplasm | 1,375 | 88.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580658 |
| 6 | = | Malignant Liver Neoplasm | 906 | 85.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580659 |
| 7 | = | Malignant Pancreatic Neoplasm | 904 | 82.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580660 |
| 8 | = | Malignant Central Nervous System Neoplasm | 823 | 80 | Medium confidence | clinicaltrials | inputs
ranking row 2580661 |
| 9 | = | Multiple Myeloma | 814 | 77.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580662 |
| 10 | = | Malignant Ovarian Neoplasm | 684 | 74.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580663 |
| 11 | = | Malignant Gastric Neoplasm | 652 | 71.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580664 |
| 12 | = | Malignant Esophageal Neoplasm | 518 | 68.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580665 |
| 13 | = | Malignant Cervical Neoplasm | 505 | 65.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580666 |
| 14 | = | Malignant Kidney Neoplasm | 453 | 62.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580667 |
| 15 | = | Malignant Uterine Corpus Neoplasm | 411 | 60 | Medium confidence | clinicaltrials | inputs
ranking row 2580668 |
| 16 | = | Malignant Rectal Neoplasm | 386 | 57.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580669 |
| 17 | = | Malignant Bladder Neoplasm | 346 | 54.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580670 |
| 18 | = | Malignant Nasopharyngeal Neoplasm | 261 | 51.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580671 |
| 19 | = | Malignant Colon Neoplasm | 225 | 48.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580672 |
| 20 | = | Hodgkin Lymphoma | 179 | 45.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580673 |
| 21 | = | Malignant Thyroid Gland Neoplasm | 176 | 42.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580674 |
| 22 | = | Malignant Lip and Oral Cavity Neoplasm | 149 | 40 | Medium confidence | clinicaltrials | inputs
ranking row 2580675 |
| 23 | = | Malignant Oropharyngeal Neoplasm | 143 | 37.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580676 |
| 24 | = | Skin Carcinoma | 127 | 34.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580677 |
| 25 | = | Malignant Mesothelioma | 96 | 31.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580678 |
| 26 | = | Cutaneous Melanoma | 78 | 28.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580679 |
| 27 | = | Malignant Anal Neoplasm | 68 | 25.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580680 |
| 28 | = | Malignant Laryngeal Neoplasm | 66 | 22.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580681 |
| 29 | = | Malignant Salivary Gland Neoplasm | 63 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580682 |
| 30 | = | Malignant Vulvar Neoplasm | 54 | 17.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580683 |
| 31 | = | Malignant Hypopharyngeal Neoplasm | 53 | 14.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580684 |
| 32 | = | Malignant Penile Neoplasm | 43 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580685 |
| 32 | = | Malignant Testicular Neoplasm | 43 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580686 |
| 34 | = | Malignant Gallbladder Neoplasm | 32 | 5.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580687 |
| 35 | = | Malignant Vaginal Neoplasm | 31 | 2.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580688 |
| 36 | = | Kaposi Sarcoma | 18 | 0 | Medium confidence | clinicaltrials | inputs
ranking row 2580689 |
Data updated 16 hours agoSource updated unknown36 eligible entities · inputs hash 36db18bc2db682c45dedd597